$RGBP The Company's focus on NR2F6 has two develo
Post# of 6702
(Total Views: 71)
Posted On: 03/02/2017 9:24:22 AM
$RGBP The Company's focus on NR2F6 has two developmental streams. The first area of development involves the inhibition of the checkpoint, NR2F6, in order to cause the body's immune system to destroy cancer cells. The second area of development involves the activation of NR2F6 which is believed to be a fulcrum for curing such autoimmune diseases as rheumatoid arthritis.
https://finance.yahoo.com/news/regen-biopharm...00603.html
https://finance.yahoo.com/news/regen-biopharm...00603.html
(0)
(0)
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!
Scroll down for more posts ▼